The global market for ELISA tests for prostate-specific antigen (PSA) is growing rapidly, and starting in 2025, these tests will be included in Ukraine’s Medical Guarantee Program. Why is this important, what trends are driving market growth, and how critical is the prostate cancer situation in Ukraine? Read on to find out more.